poractant alfa

poractant alfa (CUROSURF) is an FDA-listed pharmaceutical active ingredient. Route of administration: intratracheal. Current US regulatory status: approved.

CUROSURF is a marketed brand name for poractant alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.

poractant alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.